Sponsors and advocates say studies have proven that an overdose is the leading cause of death for people recently released ...

Padagis®, a leading generic manufacturer, announced today its over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg has now ...

US generic manufacturer Padagis has received clearance to extend the shelf life of its over-the-counter naloxone nasal spray ...

Utah's fight against opioid deaths has hit another landmark. Intermountain Health said it distributed a record number of ...

“I can save someone’s life during an overdose.” This is a statement we believe all students should be able to make by the time they graduate from high school. That’s why we — an undergraduate student ...

March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg ...

Garrett is one of the voices behind “ You Have the Power to Save Lives ,” a new campaign that urges Black communities across ...

Health Canada approves Hikma Pharma’s Kloxxado nasal spray 8 mg for treatment of known or suspected opioid overdose: London Monday, March 24, 2025, 13:00 Hrs [IST] Hikma Pharmac ...

April 2, 2025 /PRNewswire/ -- Padagis®, a leading generic manufacturer, announced today its over-the-counter (OTC) Naloxone HCl Nasal Spray 4 mg has now obtained an extended shelf-life of 36 months.

March 20, 2025 (GLOBE NEWSWIRE) -- Hikma Pharmaceuticals PLC (Hikma, Group), the multinational generic pharmaceutical company, announces the approval of KLOXXADO ® (naloxone HCl) Nasal Spray 8 mg, by ...